Published in Clin Pharmacol Ther on September 01, 2005
Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res (2013) 1.62
Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol Dial Transplant (2009) 1.49
Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. Biochim Biophys Acta (2006) 1.15
Pharmacogenetics of beta-blockers. Pharmacotherapy (2007) 1.13
Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions. Clin Pharmacol Ther (2011) 1.11
Beta-adrenoceptor blocker treatment and the cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.01
Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol (2009) 0.99
β1 adrenergic receptor polymorphisms and heart failure: a meta-analysis on susceptibility, response to β-blocker therapy and prognosis. PLoS One (2012) 0.93
Race, common genetic variation, and therapeutic response disparities in heart failure. JACC Heart Fail (2014) 0.91
Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance. Pharmacogenomics (2009) 0.90
Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy. Eur J Heart Fail (2012) 0.85
Pharmacogenetics in chronic heart failure: new developments and current challenges. Curr Heart Fail Rep (2012) 0.84
Chronic heart failure: beta-blockers and pharmacogenetics. Eur J Clin Pharmacol (2008) 0.83
S49G and R389G polymorphisms of the β₁-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways. Physiol Genomics (2013) 0.82
Beta-blocker pharmacogenetics in heart failure. Heart Fail Rev (2008) 0.81
Genetic determinants of response to cardiovascular drugs. Curr Opin Cardiol (2012) 0.80
The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
Heart failure pharmacogenetics: past, present, and future. Curr Cardiol Rep (2011) 0.78
Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor. PLoS One (2013) 0.78
The Genetic Challenges and Opportunities in Advanced Heart Failure. Can J Cardiol (2015) 0.77
Pharmacogenomics in heart failure: where are we now and how can we reach clinical application? Cardiol Rev (2014) 0.76
Effect of race on left ventricular ejection fraction decline after initial improvement with beta blockers in patients with non-ischemic cardiomyopathy: a retrospective analysis. Drugs R D (2013) 0.75
Progress toward genetic tailoring of heart failure therapy. Curr Opin Mol Ther (2010) 0.75
Pharmacogenomics of hypertension and heart disease. Curr Hypertens Rep (2015) 0.75
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure. Clin Med Insights Cardiol (2011) 0.75
Genetic polymorphisms associated with heart failure: A literature review. J Int Med Res (2016) 0.75
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J (2011) 5.11
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab (2007) 4.51
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Eur J Heart Fail (2010) 2.53
[Acute otitis media is not treated according to recommendations. Survey of treatment patterns in emergency centers and community health centers]. Lakartidningen (2004) 2.53
Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells. J Nucl Med (2002) 2.16
Effects of person-centred care in patients with chronic heart failure: the PCC-HF study. Eur Heart J (2011) 2.00
The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J Biol Chem (2008) 1.94
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90
The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem (2002) 1.63
Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur Heart J (2013) 1.49
Membrane topology and identification of key functional amino acid residues of murine acyl-CoA:diacylglycerol acyltransferase-2. J Biol Chem (2006) 1.49
Validation of a 4-item score predicting hip fracture and mortality risk among elderly women. Ann Fam Med (2007) 1.48
Network properties of complex human disease genes identified through genome-wide association studies. PLoS One (2009) 1.42
Epidemiology and primary prevention of thyroid cancer. Thyroid (2002) 1.41
Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. J Heart Lung Transplant (2007) 1.32
Exploring symptoms in chronic heart failure. Eur J Heart Fail (2005) 1.25
Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes. Diabetes Care (2005) 1.21
Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. N Engl J Med (2010) 1.20
Hydrotherapy--a new approach to improve function in the older patient with chronic heart failure. Eur J Heart Fail (2003) 1.20
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab (2009) 1.14
Reasons for seeking acute care in chronic heart failure. Eur J Heart Fail (2006) 1.13
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail (2014) 1.13
Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden. Eur J Heart Fail (2010) 1.09
Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. Eur Heart J (2008) 1.09
Incidence of hyperthyroidism in Sweden. Eur J Endocrinol (2011) 1.07
Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways. Am J Physiol Heart Circ Physiol (2006) 1.06
Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol (2003) 1.01
Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure. J Cardiovasc Pharmacol (2003) 1.01
Immersion in warm water induces improvement in cardiac function in patients with chronic heart failure. Eur J Heart Fail (2005) 0.95
Gender differences in inflammatory proteins and pathways in seasonal allergic rhinitis. Cytokine (2008) 0.94
Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease. J Am Heart Assoc (2012) 0.93
Increased IFN-gamma activity in seasonal allergic rhinitis is decreased by corticosteroid treatment. J Allergy Clin Immunol (2009) 0.91
Salt and fluid restriction is effective in patients with chronic heart failure. Eur J Heart Fail (2013) 0.90
Home care as an option in worsening chronic heart failure -- a pilot study to evaluate feasibility, quality adjusted life years and cost-effectiveness. Eur J Heart Fail (2008) 0.89
Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology (2002) 0.88
Uncertainty in illness among patients with chronic heart failure is less in person-centred care than in usual care. Eur J Cardiovasc Nurs (2013) 0.87
Self-assessed symptoms in chronic heart failure--important information for clinical management. Eur J Heart Fail (2006) 0.87
Deficiency of the lipid synthesis enzyme, DGAT1, extends longevity in mice. Aging (Albany NY) (2012) 0.86
Patients with worsening chronic heart failure who present to a hospital emergency department require hospital care. BMC Res Notes (2012) 0.86
Outcome of pulmonary valve replacements in adults after tetralogy repair: a multi-institutional study. Congenit Heart Dis (2008) 0.86
Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study. BMC Endocr Disord (2012) 0.86
Osteoporosis in a nursing home, determined by the DEXA technique. Med Sci Monit (2005) 0.86
Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study. BMC Musculoskelet Disord (2010) 0.85
Antibodies against the beta1-adrenergic receptor induce progressive development of cardiomyopathy. J Mol Cell Cardiol (2007) 0.85
Attitudes among healthcare professionals towards ICT and home follow-up in chronic heart failure care. BMC Med Inform Decis Mak (2012) 0.85
Symptom recognition and health care seeking among immigrants and native Swedish patients with heart failure. BMC Nurs (2008) 0.84
A pilot study of salt and water restriction in patients with chronic heart failure. Scand Cardiovasc J (2010) 0.84
Development of severe thyroid-associated ophthalmopathy in a patient with disseminated thyroid cancer treated with recombinant human thyrotropin/radioiodine and retinoic acid. Thyroid (2005) 0.84
Variation in plasma calcium analysis in primary care in Sweden--a multilevel analysis. BMC Fam Pract (2010) 0.84
Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in Sweden. Eur J Heart Fail (2014) 0.84
Cholesteryl esters accumulate in the heart in a porcine model of ischemia and reperfusion. PLoS One (2013) 0.83
Standard medication information is not enough: poor concordance of patient and nurse perceptions. J Adv Nurs (2007) 0.83
IgGs and Mabs against the beta2-adrenoreceptor block A-V conduction in mouse hearts: A possible role in the pathogenesis of ventricular arrhythmias. J Mol Cell Cardiol (2006) 0.83
Evaluation of a tailored, multi-component intervention for implementation of evidence-based clinical practice guidelines in primary care physical therapy: a non-randomized controlled trial. BMC Health Serv Res (2014) 0.83
Gender and age related differences in left ventricular function and geometry with focus on the long axis. Eur J Echocardiogr (2005) 0.82
Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice. Eur J Immunol (2014) 0.82
Hepatic acyl-CoA:diacylglcyerol acyltransferase (DGAT) overexpression, diacylglycerol, and insulin sensitivity. Proc Natl Acad Sci U S A (2011) 0.82
The liquorice effect on the RAAS differs between the genders. Blood Press (2006) 0.81
Benefit of warm water immersion on biventricular function in patients with chronic heart failure. Cardiovasc Ultrasound (2009) 0.81
Lower levels of the host protective IL-10 in DCM--a feature of autoimmune pathogenesis? Autoimmunity (2008) 0.81
Impaired activation of IFN-gamma+CD4+ T cells in peripheral blood of patients with dilated cardiomyopathy. Cell Immunol (2010) 0.81
Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody. Autoimmunity (2004) 0.81
Reliability of clinical muscular endurance tests in patients with chronic heart failure. Eur J Cardiovasc Nurs (2005) 0.80
The effects of hypoxia and hypercapnia on renal and heart function, haemodynamics and plasma hormone levels in stable COPD patients. Clin Respir J (2007) 0.80
Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine. Eur J Endocrinol (2010) 0.80
Right ventricular ejection fraction during exercise as a predictor of mortality in patients awaiting lung transplantation: a cohort study. BMJ Open (2013) 0.80
A review of records from follow-up visits for immigrant and Swedish patients at a heart failure clinic. Eur J Cardiovasc Nurs (2006) 0.80
Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing? Acta Oncol (2008) 0.80
Can brain natriuretic peptide (BNP) be used as a screening tool in general practice? Scand J Prim Health Care (2004) 0.79
The importance of GLUT3 for de novo lipogenesis in hypoxia-induced lipid loading of human macrophages. PLoS One (2012) 0.79
Reported adherence and social support among immigrants compared to native Swedes. J Immigr Minor Health (2009) 0.79
Long-term follow-up of patients with elevated serum calcium concentrations in Swedish primary care. Scand J Prim Health Care (2013) 0.79
TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure. Int J Cardiol (2008) 0.78
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). Eur J Heart Fail (2010) 0.78
Equality in the care and treatment of immigrants and native Swedes--a comparative study of patients hospitalised for heart failure. Eur J Cardiovasc Nurs (2007) 0.78
Risk group for hip fracture in elderly women identified by primary care questionnaire--clinical implications. Ups J Med Sci (2006) 0.78
Cardiorespiratory effects of warm water immersion in elderly patients with chronic heart failure. Clin Physiol Funct Imaging (2005) 0.77
Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine. Clin Sci (Lond) (2006) 0.77
Pulmonary oedema -- a life threatening disease. Eur J Cardiovasc Nurs (2007) 0.77
[Clinical eye for blue-coloured ears lead to the correct diagnosis: alkaptonuria]. Lakartidningen (2010) 0.76
Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor. J Heart Lung Transplant (2007) 0.76
Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation. Transpl Int (2007) 0.76
The formation of lipid droplets: possible role in the development of insulin resistance/type 2 diabetes. Prostaglandins Leukot Essent Fatty Acids (2011) 0.76
The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy. Future Cardiol (2005) 0.75
Wrong biochemistry results. Information on incidents with consequences for health should be collected centrally. BMJ (2002) 0.75
Quality of life and health care consumption in primary care patients with elevated serum calcium concentrations in - a prospective, case control, study. BMC Fam Pract (2014) 0.75
Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension. Blood Press (2014) 0.75
Relationship between blood pressure levels and adherence to medication in patients with chronic heart failure: how come? Vasc Health Risk Manag (2009) 0.75
[Catheter-based renal denervation: a new method for resistant hypertension. Initial experiences of the procedure shows significant decrease in blood pressure]. Lakartidningen (2013) 0.75
The validation of a new quality of life questionnaire for patients with congestive heart failure-an extension of the Cardiac Health Profile. Scand Cardiovasc J (2007) 0.75
[Systems biology can radically change health care. Basis for individualized prediction, prevention and treatment]. Lakartidningen (2007) 0.75
Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion. J Heart Lung Transplant (2009) 0.75
[Quality shortages in the diagnostics of thyroid nodules. National guidelines should be introduced]. Lakartidningen (2011) 0.75